Screener
Rocket Pharmaceuticals RCKT Q2 2026 earnings
Reported August 10, 2026 · After market close
EPS$1.08Beat by $0.22
Revenue estimate$222.2K
EPS estimate$0.86
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$200.0K
EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Rocket Pharmaceuticals report Q2 2026 earnings?
- Rocket Pharmaceuticals (RCKT) reported Q2 2026 earnings on August 10, 2026 after market close.
- What were Rocket Pharmaceuticals's Q2 2026 revenue and EPS?
- Rocket Pharmaceuticals reported eps of $1.08 for Q2 2026.
- Did Rocket Pharmaceuticals beat estimates in Q2 2026?
- EPS beat the consensus estimate of $0.86 by $0.22.
- Where can I find Rocket Pharmaceuticals's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001140361-26-032028) and the 10-Q periodic report (0001193125-26-342348) directly on SEC EDGAR. The filing index links above go to sec.gov.
